Bianca Santomasso
Impact in
- Oncology top 0.1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immune Cell Function and Interaction
Papers in
- Co-authors
- Elena Mead (9 shared papers)Craig Steven Sauter (7 shared papers)Isabelle Rivière (4 shared papers)Renier J. Brentjens (5 shared papers)Jae H. Park (5 shared papers)Michel Sadelain (3 shared papers)Xiuyan Wang (2 shared papers)Brigitte Sénéchal (3 shared papers)
- Journals
- Transplantation and Cellular Therapy (9 papers)Neuro-Oncology (5 papers)Journal of the National Comprehensive Cancer Network (4 papers)Blood (4 papers)Blood Advances (4 papers)
- Partner nations
- United StatesItalyIndia
In The Last Decade
Bianca Santomasso
58 papers receiving 14.3k citations
Bianca Santomasso's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 11.5k
- Immunology 2.0k
- Hematology 1.1k
- Genetics 660
- Genetics 1.5k
Countries citing papers authored by Bianca Santomasso
This map shows the geographic impact of Bianca Santomasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bianca Santomasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bianca Santomasso more than expected).
Fields of papers citing papers by Bianca Santomasso
This network shows the impact of papers produced by Bianca Santomasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bianca Santomasso. The network helps show where Bianca Santomasso may publish in the future.
Co-authors
The 25 scholars most cited alongside Bianca Santomasso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Hit paper breakdown → | 2018 | 2972 |
| 2 | ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells Hit paper breakdown → | 2018 | 2781 |
| 3 | Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia Hit paper breakdown → | 2018 | 2196 |
| 4 | Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia Hit paper breakdown → | 2018 | 735 |
| 5 | G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator Hit paper breakdown → | 1998 | 734 |
| 6 | Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events Hit paper breakdown → | 2021 | 652 |
| 7 | Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 469 |
| 8 | NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020 Hit paper breakdown → | 2020 | 411 |
| 9 | Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 334 |
| 10 | GPRC5D-Targeted CAR T Cells for Myeloma Hit paper breakdown → | 2022 | 326 |
| 11 | 2019 | 269 | |
| 12 | Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies Hit paper breakdown → | 2022 | 231 |
| 13 | 2020 | 228 | |
| 14 | 2020 | 225 | |
| 15 | 2020 | 203 | |
| 16 | 2021 | 171 | |
| 17 | 2021 | 159 | |
| 18 | CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results Hit paper breakdown → | 2023 | 143 |
| 19 | 2020 | 132 | |
| 20 | 2020 | 112 |
About Bianca Santomasso
Bianca Santomasso is a scholar working on Oncology, Genetics, Hematology, Pulmonary and Respiratory Medicine and Neurology, having authored 65 papers that have together received 14.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (32 papers), Cancer Immunotherapy and Biomarkers (13 papers), Brain Metastases and Treatment (8 papers), Nanowire Synthesis and Applications (7 papers), Advancements in Semiconductor Devices and Circuit Design (6 papers), Integrated Circuits and Semiconductor Failure Analysis (5 papers), Biomedical Ethics and Regulation (5 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (11.5k citations), Immunology (2.0k citations), Hematology (1.1k citations), Genetics (660 citations) and Genetics (1.5k citations). Bianca Santomasso has collaborated with scholars based in United States, Italy and India. Frequent co-authors include Elena Mead, Craig Steven Sauter, Isabelle Rivière, Renier J. Brentjens, Jae H. Park, Michel Sadelain, Xiuyan Wang, Brigitte Sénéchal, Kevin Joseph Curran and Peter George Maslak. Their work appears in journals such as Transplantation and Cellular Therapy, Neuro-Oncology, Journal of the National Comprehensive Cancer Network, Blood and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.